Abstract

Basics of Compounding for Cough

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2004 - Endotoxin

Page(s): 462-465

Download in electronic PDF format for $75

Abstract

Cough is a symptom of a number of pathologic conditions, including infections and pulmonary, cardiac, and gastrointestinal disorders. It also can be caused by medication. While numerous prescription and nonprescription treatments for cough are available, these are not suitable for all patients in all situations. Extemporaneous compounding allows preparation of customized formulations that contains a variety of difference components in a dosage form convenient for the patient. Formulas and methods are provided for several frequently prescribed compounds. The initial step in treating cough is eliminating exposure to any irritant or discontinuing any medication that might be causing the cough. Depending on the cause of the cough, drug therapies include antihistamines (with or without decongestant), intranasal or oral corticosteroids, antibiotics, bronchodilators, topical volatile agents (eg, camphor, menthol, thymol), guaifenesin (antitussive/expectorant), or centrally acting drugs that suppress the cough reflex (codeine sulfate, dextromorphan hydrobromide, hydrocodone bitartrate, hydromorphone hydrochloride).

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2003 Pg. 129-134 View Sample	Basics of Compounding for Terrorist Attacks, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 401-405	Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Nov/Dec 2015 Pg. 504	Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 480-483	Colds and Cough Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 388	Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 386	Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 387	Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 516-521	Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Mar/Apr 2010 Pg. 105-107	Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword? Author(s): Williams LaVonn A
Mar/Apr 2010 Pg. 171-173	Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
May/Jun 2009 Pg. 224-229	Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education Author(s): McElhiney Linda F
Jan/Feb 2017 Pg. 6-16	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 Author(s): Deleruyelle Laura J
Jul/Aug 2003 Pg. 304	Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 291-294	The Basics of Compounding: Compounding Special Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 388-392	Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing Author(s): Allen Loyd V Jr
Jan/Feb 2002 Pg. 46	Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules Author(s): Allen Loyd V Jr